Research&Innovation
Home > Research&Innovation > R&D Profile
 

R&D and continuous Technology Innovation is the driving force for sustainable development. Acebright has established one national key laboratory (the National Key Laboratory of Antibody Drugs Research), one national enterprise technology center (the Shanghai Acebright Pharmaceuticals Group Technology Center), one provincial enterprise technology center (the Chifeng Pharma Technology Center) and a postdoctoral research station (the Shanghai Desano Pharmaceutical Postdoctoral Research Station).

We have undertaken a series of national key research and development projects (such as new drugs research and development projects of the “863”and“125” plans)in our R&D centers. We have completed or are conducting 15 national R&D projects and about 50 provincial R&D programs.

 
All Rights Reserved:Shanghai Acebright Pharmaceuticals Group Co., Ltd. 2018
ICP:NO.12044760